Larimar Therapeutics (STU:ZA71) Other Long Term Assets : €1.77 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Larimar Therapeutics Other Long Term Assets?

Larimar Therapeutics's other long-term assets for the quarter that ended in Sep. 2024 was €1.77 Mil.

Larimar Therapeutics's quarterly other long-term assets declined from Mar. 2024 (€1.86 Mil) to Jun. 2024 (€1.83 Mil) but then stayed the same from Jun. 2024 (€1.83 Mil) to Sep. 2024 (€1.77 Mil).

Larimar Therapeutics's annual other long-term assets increased from Dec. 2021 (€1.78 Mil) to Dec. 2022 (€1.87 Mil) but then declined from Dec. 2022 (€1.87 Mil) to Dec. 2023 (€1.83 Mil).

Larimar Therapeutics Other Long Term Assets Historical Data

The historical data trend for Larimar Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Larimar Therapeutics Other Long Term Assets Chart

Larimar Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

0.08

1.45

1.78

1.87

1.83

Larimar Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Long Term Assets	Get a 7-Day Free Trial															1.85	1.83	1.86	1.83	1.77

Larimar Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Larimar Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Larimar Therapeutics Inc (STU:ZA71) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

LRMR:USA

Address

Three Bala Plaza East, Suite 506, Bala Cynwyd, PA, USA, 19004

Website

https://www.larimartx.com

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Larimar Therapeutics Headlines

No Headlines